Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

22. Mai 2013 08:00 ET | Quelle: Chelsea Therapeutics

Chelsea Therapeutics to Present at the 38th Annual Deutsche Bank Health Care Conference

CHARLOTTE, N.C., May 22, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 38th Annual Deutsche Bank Health Care Conference at 4:50 PM on...
01. Mai 2013 16:16 ET | Quelle: Chelsea Therapeutics

Chelsea Therapeutics Reports First Quarter 2013 Financial Results

CHARLOTTE, N.C., May 1, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the first quarter ended March 31, 2013. "In the first...
24. April 2013 09:25 ET | Quelle: Chelsea Therapeutics

Chelsea Therapeutics to Present at the 12th Annual Needham Healthcare Conference

CHARLOTTE, N.C., April 24, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present the 12th Annual Needham Healthcare Conference at 10:40 AM on...
19. März 2013 08:00 ET | Quelle: Chelsea Therapeutics

Chelsea Therapeutics Announces Presentation of Northera(TM) (droxidopa) Study 306 Data at the American Academy of Neurology Annual Meeting

CHARLOTTE, N.C., March 19, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that Dr. Stuart Isaacson, Clinical Associate Professor, Department of...
12. März 2013 07:00 ET | Quelle: Chelsea Therapeutics

Chelsea Therapeutics to Present at the 25th Annual ROTH Conference

CHARLOTTE, N.C., March 12, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 25TH Annual ROTH Conference at 3:30 PM PT on Tuesday, March...
07. März 2013 16:17 ET | Quelle: Chelsea Therapeutics

Chelsea Therapeutics Reports Fourth Quarter and Full-Year 2012 Results

CHARLOTTE, N.C., March 7, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the fourth quarter and full year ended December 31,...
20. Februar 2013 07:00 ET | Quelle: Chelsea Therapeutics

Chelsea Therapeutics Receives FDA Guidance for a Northera(TM) (Droxidopa) NDA Resubmission With Study 306B

Company to Resubmit NDA in Late Second Quarter 2013 Short-term Clinical Benefit Adequate to Support Approval Company to Host Conference Call Today at 9:00 AM ET CHARLOTTE,...
04. Dezember 2012 16:05 ET | Quelle: Chelsea Therapeutics

Chelsea Therapeutics Announces Northera(TM) (Droxidopa) Study 306B Meets Primary Endpoint

Northera™ Demonstrated Statistically Significant Improvement Over Placebo in Reduction of Dizziness/Lightheadedness at Week 1 (p=0.018), the Primary Endpoint, and Standing Blood Pressure at...
07. November 2012 16:16 ET | Quelle: Chelsea Therapeutics

Chelsea Therapeutics Reports Third Quarter 2012 Financial Results

CHARLOTTE, N.C., Nov. 7, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the quarter and nine months ended September 30,...
06. November 2012 08:00 ET | Quelle: Chelsea Therapeutics

Chelsea Therapeutics Announces Results From Northera(TM) (droxidopa) Study in Spinal Cord Injury at the 23rd International Symposium on the Autonomic Nervous System

CHARLOTTE, N.C., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced results from a study of Northera™ (droxidopa) in hypotensive individuals...

Vorherige Seite

Nächste Seite